Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.
- DOI
- 10.1038/s41591-025-03918-x
- Published
- 2025 Oct
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-025-03918-x,
title = {Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.},
author = {Marchetti P and Curigliano G and Biffoni M and Lonardi S and Scagnoli S and Fornaro L and Guarneri V and De Giorgi U and Ascierto PA and Blandino G and D'Amati G and Aglietta M and Cremolini C and Conte P and Crimini E and Ceracchi M and Pisegna S and Verkhovskaia S and Bordonaro R and Bracarda S and Butturini G and Del Mastro L and DeCensi A and Fabbri A and Fenocchio E and Gori S and Metro G and Pessino A and Pozzessere D and Puglisi F and Tamberi S and Zambelli A and Marino D and Capoluongo E and Cappuzzo F and Cerbelli B and Giannini G and Malapelle U and Mazzuca F and Nuti M and Pruneri G and Simmaco M and Strigari L and Tonini G and Martini N and Botticelli A and ROME trial investigators consortia},
year = {2025},
journal = {Nature medicine},
doi = {10.1038/s41591-025-03918-x},
url = {https://doi.org/10.1038/s41591-025-03918-x}
}RIS
TY - JOUR TI - Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial. AU - Marchetti P AU - Curigliano G AU - Biffoni M AU - Lonardi S AU - Scagnoli S AU - Fornaro L AU - Guarneri V AU - De Giorgi U AU - Ascierto PA AU - Blandino G AU - D'Amati G AU - Aglietta M AU - Cremolini C AU - Conte P AU - Crimini E AU - Ceracchi M AU - Pisegna S AU - Verkhovskaia S AU - Bordonaro R AU - Bracarda S AU - Butturini G AU - Del Mastro L AU - DeCensi A AU - Fabbri A AU - Fenocchio E AU - Gori S AU - Metro G AU - Pessino A AU - Pozzessere D AU - Puglisi F AU - Tamberi S AU - Zambelli A AU - Marino D AU - Capoluongo E AU - Cappuzzo F AU - Cerbelli B AU - Giannini G AU - Malapelle U AU - Mazzuca F AU - Nuti M AU - Pruneri G AU - Simmaco M AU - Strigari L AU - Tonini G AU - Martini N AU - Botticelli A AU - ROME trial investigators consortia PY - 2025 JO - Nature medicine DO - 10.1038/s41591-025-03918-x UR - https://doi.org/10.1038/s41591-025-03918-x ER -
APA
P, M., G, C., M, B., S, L., S, S., L, F., V, G., U, D. G., PA, A., G, B., G, D., M, A., C, C., P, C., E, C., M, C., S, P., S, V., R, B., S, B., G, B., L, D. M., A, D., A, F., E, F., S, G., G, M., A, P., D, P., F, P., S, T., A, Z., D, M., E, C., F, C., B, C., G, G., U, M., F, M., M, N., G, P., M, S., L, S., G, T., N, M., A, B., & consortia, R. T. I. (2025). Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.. Nature medicine. https://doi.org/10.1038/s41591-025-03918-x
Source records
- pubmed · retrieved 2026-09-26T01:05:10.889Z